Grant opportunity
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)
The goal of the Paul Calabresi Career Development Award for Clinical Oncology (PCACO) is to increase the number of clinician-scientists trained in clinical and translational cancer research, and to promote their career development as cancer researchers.
- Funder
- National Institutes of Health / Department of Health and Human Services
- Closes 2029-03-12
- Closes 2029-03-12: Mar 12, 2029
- Award
- up to none; floor none
- Applicant
- Organizations and Institutions
- Discipline
- Health and Biomedical Sciences
- Region
- United States
- Posted
- Jun 3, 2026
Call summary
Overview
The goal of the Paul Calabresi Career Development Award for Clinical Oncology (PCACO) is to increase the number of clinician-scientists trained in clinical and translational cancer research, and to promote their career development as cancer researchers. This Notice of Funding Opportunity (NOFO) does not allow Scholars to propose to lead an independent clinical trial, but does allow Scholars to propose research experience in a clinical trial led by a mentor or co-mentor.
Who can apply
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
What it supports
- Health and Biomedical Sciences
- United States
- Official opportunity number: PAR-27-025.
Funding and duration
- up to none; floor none
Closes 2029-03-12
Closes 2029-03-12: Mar 12, 2029
How to apply
Use the official Grants.gov listing for application package, forms, attachments, and agency-specific instructions. Submit by 2029-03-12 unless the agency updates the official listing.
Call details
Source-based overview
The goal of the Paul Calabresi Career Development Award for Clinical Oncology (PCACO) is to increase the number of clinician-scientists trained in clinical and translational cancer research, and to promote their career development as cancer researchers. This Notice of Funding Opportunity (NOFO) does not allow Scholars to propose to lead an independent clinical trial, but does allow Scholars to propose research experience in a clinical trial led by a mentor or co-mentor. Eligibility: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. Opportunity number: PAR-27-025. Closing date: 2029-03-12. Funding: up to none; floor none.
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Funding and benefits
up to none; floor none
Themes and supported activities
Health and Biomedical Sciences
United States
Official opportunity number: PAR-27-025.
Deadline and timeline
Closes 2029-03-12: Closes 2029-03-12: Mar 12, 2029.
Applicants should confirm the exact deadline time, time zone, required documents, portal steps and any institutional approvals on the official call page before submitting.
How to apply
Use the official Grants.gov listing for application package, forms, attachments, and agency-specific instructions. Submit by 2029-03-12 unless the agency updates the official listing.
Before applying, check eligibility rules, budgets, attachments, page limits, partner requirements, cost-share conditions and whether the opportunity uses an expression of interest, full proposal, registration or nomination stage.